AVADO: Bevacizumab/docetaxel provides small benefit in PFS. Commentary

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'AVADO: Bevacizumab/docetaxel provides small benefit in PFS. Commentary'. Together they form a unique fingerprint.